Relative affinities of drugs acting at cholinoceptors in displacing agonist and antagonist radioligands: the NMS/Oxo-M ratio as an index of efficacy at cortical muscarinic receptors
- PMID: 3359114
- PMCID: PMC1853815
- DOI: 10.1111/j.1476-5381.1988.tb11451.x
Relative affinities of drugs acting at cholinoceptors in displacing agonist and antagonist radioligands: the NMS/Oxo-M ratio as an index of efficacy at cortical muscarinic receptors
Abstract
1. Radioligand binding assays using [3H]-N-methylscopolamine (NMS) and [3H]-oxotremorine M (Oxo-M) have been devised to predict the efficacy of test compounds at muscarinic receptors in rat cerebral cortex. 2. Muscarinic antagonists, including non-selective and both M1- and M2-selective compounds, displayed similar affinity for both binding assays. 3. Full agonists such as carbachol and muscarine possessed a ratio of potencies against the antagonist versus the agonist ligand (NMS/Oxo-M ratio) of greater than 4000. 4. Compounds which have been shown previously to display partial agonist activity in functional assays e.g. pilocarpine and RS86 had intermediate NMS/Oxo-M ratios of 100-150. A second group of compounds which included oxotremorine had somewhat higher ratios (500-1400). 5. The ratio of affinity constants for the two assays predicted the ability of agonists to stimulate cortical phosphatidyl-inositol turnover. 6. These results suggest that the NMS/Oxo-M ratio may be a useful prediction of efficacy for novel compounds acting at cortical muscarinic receptors.
Similar articles
-
Affinities of muscarinic drugs for [3H]N-methylscopolamine (NMS) and [3H]oxotremorine (OXO) binding to a mixture of M1-M4 muscarinic receptors: use of NMS/OXO-M ratios to group compounds into potential agonist, partial agonist, and antagonist classes.Neurochem Res. 1995 Jun;20(6):669-74. doi: 10.1007/BF01705534. Neurochem Res. 1995. PMID: 7566362
-
L-689,660, a novel cholinomimetic with functional selectivity for M1 and M3 muscarinic receptors.Br J Pharmacol. 1992 Oct;107(2):494-501. doi: 10.1111/j.1476-5381.1992.tb12773.x. Br J Pharmacol. 1992. PMID: 1422595 Free PMC article.
-
Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.Mol Pharmacol. 1987 Jul;32(1):100-8. Mol Pharmacol. 1987. PMID: 3600611
-
Evaluation of an agonist index: affinity ratio for compounds active on muscarinic cholinergic M2 receptors.J Auton Pharmacol. 1999 Apr;19(2):77-84. doi: 10.1046/j.1365-2680.1999.00118.x. J Auton Pharmacol. 1999. PMID: 10466939
-
The design of novel muscarinic partial agonists that have functional selectivity in pharmacological preparations in vitro and reduced side-effect profile in vivo.Life Sci. 1993;52(5-6):489-95. doi: 10.1016/0024-3205(93)90306-n. Life Sci. 1993. PMID: 8441329 Review.
Cited by
-
SR 46559A: a novel and potent muscarinic compound with no cholinergic syndrome.Psychopharmacology (Berl). 1993;112(2-3):219-27. doi: 10.1007/BF02244914. Psychopharmacology (Berl). 1993. PMID: 7871023
-
Rotigotine is a potent agonist at dopamine D1 receptors as well as at dopamine D2 and D3 receptors.Br J Pharmacol. 2015 Feb;172(4):1124-35. doi: 10.1111/bph.12988. Epub 2015 Jan 13. Br J Pharmacol. 2015. PMID: 25339241 Free PMC article.
-
Affinities of muscarinic drugs for [3H]N-methylscopolamine (NMS) and [3H]oxotremorine (OXO) binding to a mixture of M1-M4 muscarinic receptors: use of NMS/OXO-M ratios to group compounds into potential agonist, partial agonist, and antagonist classes.Neurochem Res. 1995 Jun;20(6):669-74. doi: 10.1007/BF01705534. Neurochem Res. 1995. PMID: 7566362
-
G alpha(q)-coupled muscarinic acetylcholine receptors enhance nicotinic acetylcholine receptor signaling in Caenorhabditis elegans mating behavior.J Neurosci. 2007 Feb 7;27(6):1411-21. doi: 10.1523/JNEUROSCI.4320-06.2007. J Neurosci. 2007. PMID: 17287516 Free PMC article.
-
L-689,660, a novel cholinomimetic with functional selectivity for M1 and M3 muscarinic receptors.Br J Pharmacol. 1992 Oct;107(2):494-501. doi: 10.1111/j.1476-5381.1992.tb12773.x. Br J Pharmacol. 1992. PMID: 1422595 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources